Bio Competitors
| BIO Stock | USD 279.83 0.52 0.19% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bio Rad competition on your existing holdings.
Bio |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio Rad's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bio Rad Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bio Rad and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bio Rad Laboratories does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Bio Stock performing well and Bio Rad Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Rad's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NARI | 2.27 | (0.46) | 0.00 | (0.38) | 0.00 | 5.29 | 24.21 | |||
| CNMD | 1.97 | (0.43) | 0.00 | (0.70) | 0.00 | 2.96 | 15.54 | |||
| GKOS | 1.58 | 0.16 | 0.12 | 0.16 | 1.51 | 3.99 | 7.99 | |||
| NVRO | 2.66 | (0.72) | 0.00 | (0.19) | 0.00 | 5.52 | 15.00 | |||
| MDT | 0.82 | (0.17) | 0.00 | (0.10) | 0.00 | 1.40 | 6.33 | |||
| MGRM | 5.54 | (0.41) | 0.00 | (0.07) | 0.00 | 6.61 | 102.88 | |||
| BFLY | 5.01 | 0.04 | 0.04 | 0.08 | 5.43 | 12.78 | 49.99 | |||
| INMD | 1.95 | (0.57) | 0.00 | (0.19) | 0.00 | 3.19 | 16.04 | |||
| ABT | 0.89 | (0.15) | 0.00 | (0.12) | 0.00 | 1.78 | 5.33 | |||
| SYK | 0.76 | (0.10) | 0.00 | (0.04) | 0.00 | 1.61 | 5.39 |
Cross Equities Net Income Analysis
Compare Bio Rad Laboratories and related stocks such as Inari MedicalInc, CONMED, and Glaukos Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NARI | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (10.2 M) | (1.9 M) | 13.8 M | 9.8 M | (29.3 M) | (1.6 M) | (1.7 M) |
| CNMD | 700 K | 752 K | 40.5 M | 35.9 M | 32.2 M | 30.5 M | 14.7 M | 55.5 M | 40.9 M | 28.6 M | 9.5 M | 62.5 M | (80.6 M) | 64.5 M | 67.7 M |
| GKOS | (12.6 M) | (12.6 M) | (12.6 M) | (12.6 M) | (12.1 M) | (37.2 M) | 4.5 M | (92 K) | (13 M) | 15.4 M | (120.3 M) | (49.6 M) | (99.2 M) | (134.7 M) | (127.9 M) |
| NVRO | (19 M) | (19 M) | (19 M) | (26 M) | (30.7 M) | (67.4 M) | (31.8 M) | (36.7 M) | (49.2 M) | (103.7 M) | (83.1 M) | (131.4 M) | 3 M | (92.2 M) | (87.6 M) |
| MDT | 53.4 M | 3.6 B | 3.5 B | 3.1 B | 2.7 B | 3.5 B | 4 B | 3.1 B | 4.6 B | 4.8 B | 3.6 B | 5 B | 3.8 B | 4.3 B | 4.5 B |
| MGRM | (659 K) | (659 K) | (659 K) | (659 K) | (659 K) | (659 K) | (659 K) | (659 K) | (712.3 K) | (1.8 M) | (9.1 M) | (11.8 M) | (13.7 M) | (13.7 M) | (13.1 M) |
| BFLY | (99.6 M) | (99.6 M) | (99.6 M) | (99.6 M) | (99.6 M) | (99.6 M) | (99.6 M) | (99.6 M) | (99.6 M) | (99.6 M) | (162.7 M) | (32.4 M) | (168.7 M) | (133.7 M) | (140.4 M) |
| INMD | 336 K | 336 K | 336 K | 336 K | 336 K | 336 K | 336 K | 8.8 M | 22.4 M | 61.1 M | 75 M | 165 M | 161.5 M | 197.9 M | 207.8 M |
| ABT | 465.3 M | 4.7 B | 6 B | 2.6 B | 2.3 B | 4.4 B | 1.4 B | 477 M | 2.4 B | 3.7 B | 4.5 B | 7.1 B | 6.9 B | 5.7 B | 3.1 B |
| SYK | 8.4 M | 1.3 B | 1.3 B | 1 B | 515 M | 1.4 B | 1.6 B | 1 B | 3.6 B | 2.1 B | 1.6 B | 2 B | 2.4 B | 3.2 B | 3.3 B |
Bio Rad Laboratories and related stocks such as Inari MedicalInc, CONMED, and Glaukos Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Bio Rad Laboratories financial statement analysis. It represents the amount of money remaining after all of Bio Rad Laboratories operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Bio Rad Competitive Analysis
The better you understand Bio Rad competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bio Rad's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bio Rad's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Bio Rad Competition Performance Charts
Five steps to successful analysis of Bio Rad Competition
Bio Rad's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bio Rad Laboratories in relation to its competition. Bio Rad's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Bio Rad in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bio Rad's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bio Rad Laboratories, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Bio Rad position
In addition to having Bio Rad in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bio Rad Correlation with its peers. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.56) | Earnings Share (21.83) | Revenue Per Share 91.453 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0177 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.